重症医学科体外膜肺氧合支持期间患者医院感染危险因素

Risk factors for hospital-associated infections in patients during extracorporeal membrane oxygenation support in intensive care unit

  • 摘要:
    目的 探讨重症医学科(ICU)接受体外膜肺氧合(ECMO)支持治疗患者发生医院感染的流行病学特征及其危险因素,为临床防控提供依据。
    方法 回顾性分析2018年1月-2024年12月常州市第一人民医院ICU收治的84例ECMO患者的基本信息,分析医院感染发生率、感染部位、病原菌;采用单因素分析及二元logistic回归分析ECMO支持治疗期间医院感染危险因素。
    结果 84例ECMO支持治疗患者中,28例发生医院感染, 感染例次44例。感染部位以呼吸系统为主(63.64%),其次为泌尿系统(15.91%)。病原菌以革兰阴性菌为主(82.76%),其中鲍曼不动杆菌(36.21%)和肺炎克雷伯菌(32.76%)为优势菌种。二元logistic回归分析显示,ECMO模式为静脉-静脉模式与使用呼吸机天数>14 d为ECMO患者发生医院感染的危险因素(P<0.05)。
    结论 ECMO支持患者医院感染风险较高,本研究为医院感染防控提供了数据支持和理论依据,临床需结合流行病学及临床实践,针对风险因素,通过早期干预策略和动态感染监测降低医院感染的发生率,改善患者预后。

     

    Abstract:
    OBJECTIVE To investigate the epidemiological characteristics and risk factors of hospital-associated infections in patients receiving extracorporeal membrane oxygenation (ECMO) support in the intensive care unit (ICU), providing a basis for clinical prevention and control.
    METHODS A retrospective analysis was conducted on the basic information of 84 ECMO patients admitted to the ICU of the First People′s Hospital of Changzhou from Jan. 2018 to Dec. 2024. The incidence, infection sites and pathogens of hospital-associated infections were analyzed. Univariate analysis and binary logistic regression analysis were used to identify risk factors for hospital-associated infections during ECMO support.
    RESULTS Among the 84 patients receiving ECMO support, 28 developed hospital-associated infections. There were 44 infection cases. The respiratory system was the primary infection site (63.64%), followed by the urinary system (15.91%). Gram-negative bacteria were the predominant pathogens (82.76%), with Acinetobacter baumannii (36.21%) and Klebsiella pneumoniae (32.76%) being the dominant species. Binary logistic regression analysis revealed that the veno-venous mode of ECMO and the use of a ventilator for more than 14 days were risk factors for hospital-associated infections in patients receiving ECMO (P < 0.05).
    CONCLUSIONS Patients receiving ECMO support have a high risk of hospital-associated infections. This study provides data support and theoretical basis for the prevention and control of hospital-associated infections. Clinically, it is necessary to combine epidemiology and clinical practice to reduce the incidence of hospital-associated infections and improve patient prognosis through early intervention strategies and dynamic infection monitoring, targeting risk factors.

     

/

返回文章
返回